Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,641 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06726460Recruiting
New rapid electrolyte test accuracy trial
This trial is testing a new, quick bedside test to measure electrolytes (like sodium and potassium) in emergency patients. It aims to see if the new test is as accurate as standard lab tests, which could help doctors make faster decisions.
Guangzhou, GuangdongAges 4 weeks+ - NCT06727162Recruiting
Ultrasound to check lymph nodes after head and neck cancer treatment
This trial uses contrast-enhanced ultrasound (a special type of ultrasound) to see how well neck lymph nodes respond to chemotherapy and immunotherapy given before surgery for head and neck squamous cell carcinoma.
Guangzhou, GuangdongAges Any age - NCT06727448Recruiting
Testing a new French sleep regularity questionnaire
This study is testing a new French questionnaire about sleep regularity. You will wear a small device (actimetry) for 14 days as part of your regular sleep check-up, and fill out the questionnaire to help doctors see if it's a good tool.
BordeauxAges 18 years+ - NCT06727617RecruitingPhase 2
Serplulimab with chemoradiation for high-risk cervical cancer
This trial tests adding an immunotherapy drug (serplulimab) to standard chemoradiation after cervical cancer surgery. It is for patients with at least two high-risk features, like lymph node spread or deep invasion, to see if it helps prevent the cancer from coming back.
Tianjin, Tianjin MunicipalityAges 18–65 - NCT06727669Recruiting
Long-term study of blood clotting and bleeding disorders
This study observes patients with blood clotting or bleeding disorders over time to collect health information and improve care.
Beijing, Beijing MunicipalityAges Any age - NCT06727864RecruitingPhase 3
Short-course treatment for low-risk active lung TB
This trial tests a shorter treatment course (instead of the standard 6 months) for people with low-risk active TB in the lungs. It aims to see if the shorter regimen works just as well and has fewer side effects.
New Taipei City, BangiaoAges 20–99 - NCT06727877Recruiting
Predicting bowel disease in premature babies using gut bacteria
This study looks at the gut bacteria of premature babies to see if changes can predict a serious bowel condition (ulcero-necrotizing enterocolitis). It aims to use artificial intelligence to help doctors catch it early.
Clermont-FerrandAges Up to 1 day - NCT06728241Recruiting
Virtual reality and AI therapy for psychosis
This study tests if virtual reality and artificial intelligence can help people with psychosis overcome difficulties going outside or doing everyday activities. It uses VR scenarios and AI tools to support treatment.
Oslo, NorwayAges 17–65 - NCT06728527Recruiting
Partial breast reconstruction with chest wall flap
This trial tests a specific type of partial breast reconstruction called a chest wall perforator flap. It's for women who previously had a lumpectomy and now want to improve the shape of their breast.
Cambridge, CambridgeshireAges 18 years+ - NCT06728956Recruiting
Online resilience training to help people with MS keep their jobs
This trial tests an online program based on Acceptance and Commitment Therapy (ACT) to build resilience and prevent job loss in people with multiple sclerosis (MS) and in healthcare workers who treat MS patients. The study will see if the program helps you stay at work and feel better.
LeedsAges 18–66 - NCT06729762Recruiting
Ultrasound-guided heat treatment for benign thyroid nodules
This study tests a treatment that uses ultrasound and heat (radiofrequency or microwave) to shrink benign thyroid nodules. It's for people who have a non-cancerous nodule that causes symptoms or worry, and who can't or don't want surgery.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06730204Recruiting
Nutritional support for children with solid tumors
This trial studies whether a standardized nutrition plan helps children with newly diagnosed solid tumors. It aims to improve treatment outcomes through better nutrition.
Shanghai, Shanghai MunicipalityAges Up to 18 years - NCT06730256RecruitingEarly Phase 1
Cell therapy for hard-to-treat multiple myeloma and plasma cell leukemia
This study tests a new cell therapy called CT0596 for people with multiple myeloma or plasma cell leukemia that is not responding to standard treatments or has come back. The therapy uses your own immune cells that are modified to fight the cancer.
Suzhou, JiangsuAges 18 years+ - NCT06730321Recruiting
Assessing skills for robotic thyroid surgery
This trial is for people having robotic thyroid surgery (removing all or part of the thyroid with a robot). It aims to create a scoring system to measure how well surgeons perform the procedure. You may be eligible if you have a small thyroid cancer or a benign nodule and want the best cosmetic result.
ShanghaiAges Any age - NCT06730373RecruitingPhase 2
RC48, sintilimab, and S-1 for advanced HER2-positive stomach cancer
This trial tests a combination of three drugs—RC48 (a targeted therapy), sintilimab (an immunotherapy), and S-1 (a chemotherapy pill)—as a first treatment for advanced HER2-positive stomach cancer that has not been treated before. The goal is to see if this triple therapy works better than current options.
Zhengzhou, HenanAges 18–75 - NCT06730503Recruiting
Glycoprotein test for lung cancer immunotherapy response
This study looks at whether certain glycoproteins in your blood can help predict how well immunotherapy works for advanced non-small cell lung cancer. You would give blood samples before and after starting an immune checkpoint inhibitor treatment.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06730529Recruiting
Using 68Ga-FAPI PET/CT scan for thyroid cancer lymph nodes
This study uses a special type of PET/CT scan (68Ga-FAPI) to see how well it finds cancer spread in lymph nodes before thyroid cancer surgery. It may help doctors plan your treatment more accurately.
Shanghai, Shanghai MunicipalityAges 16–80 - NCT06730711Recruiting
Blood pressure and stroke-related thinking changes
This study looks at how blood pressure after a stroke might affect your thinking and memory. It uses information from your hospital stay and follow-up visits to see if there is a link.
Chongqing, Chongqing MunicipalityAges 18–90 - NCT06731244Recruiting
Deciding about blood thinners after a first clot
This study helps you and your doctor decide together whether to continue blood thinners after a first unexpected blood clot. You join after 3 to 6 months of treatment to discuss your options.
Brest, FranceAges 18 years+ - NCT06731608Recruiting
Fracture prevention study for older adults in rehab
This study tests a system to help prevent another broken bone after a hip, leg, or pelvis fracture. It is for people 65+ who are in a skilled nursing facility for rehab and plan to return home or to assisted living.
Baltimore, MarylandAges 65 years+ - NCT06731920Recruiting
Ultrasound guided neck injection study
This study is testing a new way to guide a neck injection (called a cervical medial branch block) using ultrasound. It may help doctors do the procedure more safely and accurately.
Kelowna, British ColumbiaAges 19 years+ - NCT06731985Recruiting
Shorter sling tape follow-up study
This study looks at how well and how safely a shorter type of sling tape (used to treat stress urinary incontinence) works over time. It may help women who had this specific surgery between 2009 and 2020 understand their long-term results.
LorenskogAges 25–90 - NCT06732141Recruiting
Phone program for asthma anxiety and medication adherence
This study tests a telephone-based program to help people with asthma who feel anxious about using their daily inhaled steroid medication. It aims to reduce anxiety and improve how well you stick to your treatment plan.
HarbinAges 18–80 - NCT06732492RecruitingPhase 1
RD13-02 cell therapy for relapsed CD7+ NK/T lymphoma
This trial uses a new type of immune cell (RD13-02) to treat a rare and aggressive lymphoma that hasn't responded to other treatments. It targets cancer cells that carry a specific marker called CD7.
Wuhan, HubeiAges 3–70
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,641 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.